FFF Enterprises Signs Flu Vaccine Distribution Agreement with GlaxoSmithKline

June 20, 2005 Media Release

Accord Will Ensure a Secure and Reliable Distribution Channel for Fluarix Upon FDA Approval

TEMECULA, Calif. -
FFF Enterprises Inc., a healthcare corporation based in Temecula, Calif., today announced it has signed an agreement with GlaxoSmithKline for the distribution of its candidate influenza vaccine, Fluarix™. GlaxoSmithKline (GSK) recently submitted a Biological License Application to the U.S. Food and Drug Administration (FDA), to market Fluarix in the United States for immunization of adults against influenza types A and B. GSK reports that Fluarix will be available exclusively in prefilled TipLok® syringes.

Fluarix is currently licensed in over 75 countries. If it is licensed in the United States, GSK intends to supply vaccine for use in the 2005-2006 U.S. flu season. Upon FDA license approval, FFF Enterprises will manage the distribution of a majority of Fluarix in the U.S. market.

"We strongly support GlaxoSmithKline's decision to select a clearly defined channel to provide reliable, secure and easy access to Fluarix," said Patrick M. Schmidt, president and CEO of FFF Enterprises. "Only a few select distributors will be handling Fluarix, and FFF is honored by the prospect of managing the majority of GSK's flu vaccine. Coupled with our Chiron and sanofi pasteur relationships, this agreement will make FFF the nation's largest flu vaccine distributor, upon FDA approval of Fluarix."

FFF is nationally recognized for its expertise in providing stable biopharmaceutical supplies in uncertain markets, to assure products reach the patients who most need them. "Given the historic volatility of the flu vaccine supply," Schmidt explained, "FFF is committed to helping provide the United States a solution in which supply meets demand. It's a responsibility we share with all manufacturers, distributors and healthcare providers. Responsibly managing the supply is a trademark of our Guaranteed Channel Integrity™: Product availability goes hand-in-hand with channel integrity."

About FFF Enterprises Inc.
FFF Enterprises was founded in 1988 and has since grown into a multidimensional healthcare company, delivering innovative solutions in biopharmaceutical management and distribution, health information management and consumer healthcare services. FFF is now the nation's largest supplier of human plasma products, and also distributes biopharmaceuticals, vaccines and trial drugs. Customers of FFF's four divisions include members of the leading U.S. acute care and non-acute care group purchasing organizations, pharmaceutical manufacturers, biotech companies, contract research organizations, managed healthcare and consumers.

FFF's unique distribution business model has institutionalized Guaranteed Channel Integrity™, which reflects the company's commitment to purchase only from manufacturers and ship only to healthcare providers - one clear line with no gray in between. This protects products from secondary and gray markets, and enhances patient safety.